Inquiry Requested on FDA Chief’s Sudden Exit
Senators with oversight of the Food and Drug Administration asked for an inspector general’s inquiry into the circumstances surrounding the sudden resignation of the agency’s chief.
The lawmakers want information about whether Lester M. Crawford, who was confirmed to the post two months ago, followed laws that required him to report his financial assets and income to the government.
Sens. Michael B. Enzi (R-Wyo.) and Edward M. Kennedy (D-Mass.) said they wanted “a thorough review of the reasons surrounding Dr. Crawford’s resignation.”
Get the L.A. Times Politics newsletter
Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond. In your inbox three times per week.
You may occasionally receive promotional content from the Los Angeles Times.
